Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 15.66MEnterprise Value
VS
Market
Sector
Industry
History
$ 1.84Close
$ 1.53 - $ 2.27 52-Week Range
Ticker Information
Ticker
APUSCompany Name
APIMEDS PHARMACEUTICALS US INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NYSEMKTAPIMEDS PHARMACEUTICALS US INC - Enterprise Value Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
APUS - EV Historical data
| Date | Cash and Equivalents | Total Debt | Enterprise Value | Market Capitalization |
|---|---|---|---|---|
| 6/30/2025 | $ 8.74M | $ 500.1K | $ 15.66M | $ 23.89M |
| 3/31/2025 | $ 250.34K | $ 967.32K | $ 22.13M | $ 21.42M |
| 12/31/2024 | $ 3.46K | $ 673.34K | $ 0 | $ 0 |
| 9/30/2024 | $ 26.57K | $ 571.99K | $ 0 | $ 0 |
| 6/30/2024 | $ 63.33K | $ 399.46K | $ 0 | $ 0 |
| 12/31/2023 | $ 410.48K | $ 266.89K | $ 0 | $ 0 |
Key Performance Insights, Last 5 Years
- APIMEDS PHARMACEUTICALS US INC's latest trailing twelve months (TTM) EV stands at $ 0.
- Over the past 5 years, APIMEDS PHARMACEUTICALS US INC's average EV has been $ 18.9M.
- The median EV for APIMEDS PHARMACEUTICALS US INC during this period was $ 18.9M
- APIMEDS PHARMACEUTICALS US INC reached its highest EV over the past 5 years at $ 22.13M.
- The lowest EV recorded by APIMEDS PHARMACEUTICALS US INC in the same timeframe $ 15.66M
Similar metrics to Market Cap:
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Enterprise Value
[Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].Market Cap + Debt - CashnEq
(=) EV EV for APIMEDS PHARMACEUTICALS US INC is calculated as follows: Market Cap [ $ 0 ] + Debt [ $ 266.89K ] - CashnEq [ $ 410.48K ]
(=) EV [ $ 0 ] APUS - Enterprise Value, Last 5 years
$ 15.66M
Minimum
Jun 30, 2025
$ 22.13M
Maximum
Mar 31, 2025
$ 18.9M
Average
$ 18.9M
Median
EV Benchmark AnalysisMarket
The chart above depicts the distribution of EV for companies in the Total Stock Market. The average EV of the companies is $ 1.25B with a standard deviation of $ 1.66B.
The following table provides additional summary stats:
EV in the Market:
| filtered constituents | 3.33K |
|---|---|
| min | $ -1.69B |
| max | $ 6.81B |
| average | $ 1.25B |
| median | $ 438.06M |
| std | $ 1.66B |